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HAPTEN-SPECIFIC  RESPONSES  TO  THE 
PHENYLTRIMETHYLAMINO  HAPTEN 
III.  Mice Whose Delayed-type Hypersensitivity Responses Cannot  Be 
Abrogated by the Presence of Anti-Idiotypic Suppressor T  Cells Lack a 
Critical  Modulatory T  Cell Function* 
By S. JAYARAMAN AND C. J. BELLONE 
From the Department of Microbiology, St.  Louis  University School of Medicine, St.  Louis, Missouri  63104 
The immune system normally appears to exist in a stable, steady state. As proposed 
by Jerne  (1), the stability of the immune system is in part the result of a  network of 
interactions  involving  idiotypes  (Id) 1 and  anti-idiotypes  (anti-Id).  Several  systems 
have described a  critical requirement of Id recognition in the induction  of antibody 
synthesis  (2-6). Evidence has also accumulated in recent years (7, 8)  indicating that 
Id-related  mechanisms  play  a  role  in  pathways  among  interacting  T  cells  that 
eventually suppress hapten-specific delayed-type hypersensitivity (DTH). The down- 
regulation of the immune response by suppressor T  cells (Ts) is complex and not fully 
understood. Recent reports describing the heretofore unrecognized immunoregulatory 
functions of T  cells such as "contrasuppressors" (9)  and "abrosuppressors" (10)  add 
still more to the complexity involved in the biological function, immunoregulation. 
In an effort to understand the role of the idiotypic network in the regulation of the 
immune  response  to  a  small  synthetic  antigen  r-tyrosine-p-azophenyltrimethylam- 
monium  [tyr(TMA)], we have been studying the regulation  of antibody and  DTH 
responses directed to the TMA hapten.  In the course of the study, we found that a 
single injection of tyr(TMA)  in Freund's complete adjuvant  (FCA)  induced Ts that 
shut down only the cross-reactive Id  + component of the anti-TMA antibody response 
(11).  Recently  (12),  we  have characterized  the  tyr(TMA)-induced  T,  and  directly 
demonstrated the idiotype specificity of these cells by absorption procedures. Further, 
we demonstrated that these anti-idiotypic second-order Ts (T,2) cells (8) can also shut 
down DTH reactions (12) in addition to Id  + antibody formation (11).  The regulatory 
function  of these  cells  on  TMA-specific  DTH  responses  was  shown  by  adoptive 
transfer into naive recipients. However, when the anti-idiotypic T~-bearing mice were 
themselves immunized and tested for TMA specific DTH, they unexpectedly exhibited 
normal responses. Thus, although the anti-idiotypic T, could readily suppress DTH 
upon transfer to normal recipients, these same cells could not  function  intrinsically. 
* Supported by grant AI 13115 from  the U. S. Public Health Service, and by the March of Dimes Birth 
Defects Foundation. 
1  Abbreviations used in this paper:  BSS, balanced salt solution; C, complement; CY, cyclophosphamide; 
DTH, delayed-type hypersensitivity; FCA, freund's complete adjuvant; IBC, idiotype-binding capacity; 
Id, Idiotypes; ILNC, immune lymph node cells; TDTH,  T cells that mediate DTH; TMA, trimethylami- 
noaniline; TMA-SC, TMA-coupled  spleen cells; T~, T suppressor  cells; T~I, first-order  Ts; T~, second-order 
Ts; T~a, third-order Ts; tyr(TMA), L-tyrosine-p-azophenyltrimethylammonium. 
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This  anomaly  led  us  to  attempt  to  analyze  a  probable  lesion  in  the  suppressor 
pathway. The results reported here demonstrate the apparent loss of function of an 
idiotypic  T8  essential  for  the  anti-idiotypic  Ts-mediated  DTH  suppression.  This 
apparent  loss  of function  of the  idiotypic "1"8 in  anti-idiotypic T~-bearing  mice  is 
discussed as a  modulatory cell type critical for fine-tuning in immunoregulation. 
Materials  and  Methods 
Mice.  Male  A/J  (H-2  *,  Ig-l*)  mice were  obtained  from  The Jackson  Laboratory,  Bar 
Harbor, ME and were 6-8 wk of age when used in these experiments. 
Antigen Preparations.  A  110-mM solution of trimethylaminoaniline (TMA)  (Bachem  Inc., 
Torrance,  CA)  diazonium  salt  was  prepared  as  described earlier  (13).  The  procedure  for 
obtaining syngeneic spleen cells free of erythrocytes, and coupling with diazonium salt of TMA 
has already been described (14).  In brief, syngeneic spleen cells devoid of erythrocytes were 
coupled with the diazonium salt of TMA at a final concentration of 10 mM at pH 8.2. 
Immunization and Challenge.  For the induction of DTH reactivity to TMA, routinely 3 ×  107 
freshly coupled syngeneic spleen cells (TMA-SC) were injected subcutaneously into separate 
sites on the dorsal flanks of the animal. In some experiments, anti-idiotypic antisera raised in 
rabbits were  used  for  the  induction  of TMA-specific DTH.  The  induction,  isolation, and 
purification of anti-Id and  the determination of idiotype-binding capacity (IBC)  of anti-Id 
have already been described (11,  13). 1.0 lag IBC equivalent of anti-idiotypic antisera in 0.2 ml 
phosphate-buffered saline was injected subcutaneously to induce DTH  (14).  5 d after immu- 
nization by either method, mice were challenged with 25 lal of 10 mM diazonium salt in H20 
into the right footpad. The contralateral footpad was left uninjected and served as the control. 
The footpad thickness was measured with a Mitutoyo micrometer (Schlesingers for Tools Ltd., 
Brooklyn, NY) 24 h after the challenge. The magnitude of DTH reaction was expressed as the 
increment  of footpad  swelling between  the  challenged and  unchallenged control  footpads. 
Nonimmunized mice challenged similarly served as negative controls. In some experiments, for 
suppression of DTH,  20 lag IBC equivalent of anti-Id was injected intravenously through  a 
lateral tail vein 1 h before challenge as described previously (14). 
Cyclophosphamide (CY)  Treatment.  Mice were treated intraperitoneally with (CY)  (cytoxan; 
Mead Johnson  & Co.,  Evansville, IN)  reconstituted in sterile distilled H20  and  diluted in 
physiological saline. CY was administered 2 d  before immunization if 200  mg CY/kg body 
weight was used, or 1 d after immunization if 20 mg CY/kg was used. 
Induction of Suppressor Cells.  Naive A/J mice were inoculated intraperitoneally with 0.1  ml 
containing 100 lag of tyr(TMA) and FCA (containing H37Ra, Difco Laboratories, Detroit, MI). 
Spleens were obtained from tyr(TMA)-inoculated mice 6-7 wk later, and a single cell suspension 
was prepared in sterile balanced salt solution (BSS). Viability was determined using trypan 
blue dye exclusion method. To adoptively transfer suppression, 6 ×  107 viable splenic cells were 
inoculated intravenously through a  lateral tail vein. To study the intrinsic unresponsiveness, 
tyr(TMA)-immunized mice were injected subcutaneously with TMA-SC or anti-Id, usually 6- 
7 wk after tyr(TMA) inoculation, except when specifically mentioned, and challenged in the 
footpad 5 d later. 
Adoptive Transfer and Treatment of Lymph Node Cells.  Mice were immunized with TMA-SC, 
and 5 d  later the animals were killed. The superficial cervical, axillary, brachial, superficial 
inguinal, and mesentenic lymph nodes were removed, and a single-cell suspension was prepared 
using a fine mesh screen. After washing, viability was determined and desired number of cells 
were resuspended in BSS. Before adoptive transfer, the lymph node cells were treated with 
several reagents, washed extensively in BSS, and resuspended in BSS at a desired density. 
The cells were suspended at 1 ×  107 cells/ml concentration in BSS for treatment with several 
reagents.  Anti-Thy  1  monoclonal  antibody  secreted  by  the  hybridoma  T24/40.7  (kindly 
provided by Dr. J. Kappler and Dr. P. Marrack, The National Jewish Hospital, Denver) was 
used at  1:30 dilution. Anti-Lyt.2 monoclonal antibody secreted by the hybridoma 2.43.1  and 
anti-Lyt. 1 monoclonal antibody secreted by the hybridoma 78.10.1  were used at 1:50 dilution. 
Both hybridomas were obtained from Dr. Barbara Araneo (The Jewish  Hospital, St. Louis) 
and  were originally produced in  Dr.  Frank Fitch's laboratory, University of Chicago. Cells 1812  IDIOTYPIC  T  CELLS  THAT  MODULATE  SUPPRESSION 
were incubated with antisera for 1 h on ice, spun, and resuspended at 3.3 ×  107/ml concentration 
and incubated at 37°C for 30 min with low toxic rabbit complement  (C) at  1:30 dilution. After 
incubation cells were extensively washed and used for transfer. Treatment  of lymph node cells 
with anti-Id antisera and C  was performed according to the method described by Sy et al. (15). 
Briefly, lymph  node cells were suspended at  107 cells/ml in BSS and  incubated  on ice for  1 h 
with 25 #g IBC equivalent of anti-Id per every 108 cells. After incubation with anti-Id sera, cells 
were  spun  and  resuspended  in  rabbit  C  (1:30)  and  incubated  at  37°C  for  30  min.  All  the 
lymph  node  cell  preparations  were  injected  intravenously through  the  lateral  tail  vein  into 
appropriate  recipients. The mice were challenged in the footpad within  1 h  of cell  transfer. 
Statistical Analysis.  All data were analyzed  for significance by using a  two-tailed  Student's 
t  test.  Percent  suppression was calculated  using the formula:  percent  suppression =  ([positive 
control  -  experimental  group]/[positive  control  -  negative control])  ×  100.  More  than  50% 
suppression was always highly significant. 
Results 
Transferable Suppression and Intrinsic  Unresponsiveness.  Mice were injected intraperi- 
toneally with tyr(TMA) in FCA. These will be referred to as tyr(TMA)-immune mice. 
Spleen cells obtained from these mice 6 wk after tyr(TMA) injection when transferred 
intravenously into normal mice suppressed the DTH responses induced with TMA- 
SC  (12).  In conformity with this,  we observed that  tyr(TMA)-immune spleen cells 
suppressed the DTH responses of normal mice immunized either with TMA-coupled 
spleen cells (TMA-SC) or anti-Id antibodies (Table I) at the effector phase. However, 
when tyr(TMA)-immune mice were immunized with TMA-SC or anti-Id antibodies, 
no suppression was observed. This is referred to as the lack of intrinsic unresponsive- 
ness.  Thus, the tyr(TMA)  inoculation of A/J  mice led to the development of anti- 
TABLE  I 
Lack of Intrinsic Unresponsiveness  in  T~e-bearing Mice* 
Percent  Immuni-  Chal- 
Group  Treatment  zation  lenge  Response  suppres- 
sion 














--  TMA-SC  +  1.12 +  0.10 (5)  -- 
tyr(TMA)  TMA-SC  +  1.45 ±  0.15 (4)  -46 
--  Anti-Id  +  0.90 +  0.10 (7)  -- 
tyr(TMA)  Anti-Id  +  0.84 ±  0.06 (7)  12 
tyr(TMA)  --  +  0.53 ±  0.13 (4)  -- 
--  --  +  0.40 ±  0.04 (4)  -- 
--  TMA-SC  +  0.78 +  0.05 (4)  -- 
splenic suppressor cells  TMA-SC  +  0.43 +  0.10 (4)  79 
--  Anti-Id  +  0.83 +  0.08 (11)  -- 
splenic suppressor cells  Anti-Id  +  0.56 +  0.03 (8)  63 
--  --  +  0.40 +  0.03 (5)  -- 
* A/J mice were immunized with either 3 ×  10  r TMA-SC or 1.0 #g IBC equivalent ofanti-Id and 5 d later 
challenged in the footpad with activated diazonium salt of TMA. Footpad swelling was measured 24 h 
later. Number of mice tested is given in parentheses. Percent suppression was calculated as described in 
Materials and Methods. In the experiment to study the intrinsic unresponsiveness, mice were inoculated 
intraperitoneally with 100 p~g of tyr(TMA) +  FCA 6 wk before immunization. The ability of suppressor 
cells generated by tyr(TMA)  +  FCA injection 6  wk before, was tested by transferring 6  ×  l0  7 splenic 
suppressor ceils intravenously through a  lateral tail vein into normal mice immunized with appropriate 
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TABLE II 
Kinetics of Intrinsic Unresponsiveness* 
Period after tyr(TMA)  Response  Percent 
inoculation  suppression 
mm ± 1 SEM 
'Experiment A 
Positive controls  0.90 + 0.04 (4)  -- 
1 wk  0.84 + 0.08 (5)  10 
2 wk  0.50 ± 0.06 (3)  645 
3 wk  0.78 ± 0.05 (4)  19 
4 wk  0.75 ± 0.06 (4)  23 
6 wk  0.98 + 0.12 (4)  -13 
Negative controls  0.27 ± 0.03 (3)  -- 
Experiment B 
Positive controls  1.40 ± 0.10 (5)  -- 
2 wk  0.72 + 0.10 (5)  68:]: 
8 wk  1.10 ± 0.10 (3)  30 
9 wk  1.13 ± 0.06 (4)  27 
10 wk  1.30 ± 0.10 (4)  10 
Negative controls  0.40 ± 0.05 (5)  -- 
* A/J mice  were immunized with 3 ×  107 TMA-SC at different time intervals 
after 100 btg of tyr(TMA) + FCA inoculation and challenged in the footpad 
5 d later. Footpad swelling was measured 24 h after challenge. Number of 
mice tested is given in parentheses. Positive  controls indicate the response  of 
normal  A/J  mice that  received no tyr(TMA)  +  FCA. Naive mice not 
immunized with TMA-SC  but challenged in the  footpad served as  the 
negative controls. 
$ Significantly different from positive controls; P < 0.01. 
idiotypic T,2 (12), which could transfer suppression to normal mice without obviously 
impairing the ability of tyr(TMA)-immune mice to mount a  normal DTH  response 
when immunized with TMA-SC or anti-Id antibodies. Since no intrinsic suppression 
was  noted at  the  6-wk period, we  next determined if tyr(TMA)  inoculation led  to 
intrinsic unresponsiveness at some earlier or later time point. Accordingly, mice were 
inoculated with tyr(TMA) in FCA and each week thereafter immunized with TMA- 
SC  and  assayed  for  DTH  reactivity 5  d  later.  As  seen  in Table II,  no significant 
suppression was seen at 3 wk and thereafter up to  10 wk after tyr(TMA) inoculation. 
The lack of suppression at the  1-wk period was not surprising, as we have previously 
shown  (16)  that  this  population does  not  contain suppressor  activity, but  in  fact 
contains T  cell mediated helper activity for anti-TMA antibody production. Clear- 
cut  suppression was  noted only at  the  2-wk period,  but  this suppression is clearly 
mediated by idiotypic Tax  with  different functional and phenotypic characteristics 
from that of anti-idiotypic T~ induced 6 wk after tyr(TMA) injection (manuscript in 
preparation). 
In summary, the data presented indicate that tyr(TMA) inoculation first leads to 
the appearance of idiotypic T~I which can function intrinsically. At later time points 
(6 wk) anti-idiotypic T~2 emerge (12), which can only be detected by adoptive transfer 
experiments (see Table I). The failure of these T~2 to function intrinsically led us into 
a  series of experiments to understand this apparent anomaly. 
Lack of  Intrinsic Unresponsiveness Is Not Caused by CompensatoTy Increases of ld-  T cells that 
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the TDTn population  bear surface Id + receptors. Given these facts, it was possible that 
the anti-idiotypic T~ were suppressing Id  + TDTn, which then resulted in the expression 
of a  compensating  Id-  TDTH  population  after TMA-SC  inoculation.  If this were  the 
case,  then  inoculation of the anti-Id just  before challenge should not  block the DTH 
response in the tyr(TMA)-primed  group.  As shown  in Table  III, the DTH  responses 
in  the  normal  as  well  as  the  tyr(TMA)-immune  mice  were  blocked  equally  well, 
suggesting an intact Id + TDTH component.  In addition, the blocking of DTH  by anti- 
Id  occurred  even  when  mice  were  pretreated  with  high  or  low  doses  of CY.  This 
suggests  that  the  anti-Id-mediated  suppression  is  not  the  result  of the  activation  of 
CY-sensitive suppressor  cells by the anti-Id,  but  rather  a  blockade  or elimination  of 
Id  +  TDTn.  Thus,  it  appears  that  the  Id +  component  of the TDTH  is  not  remarkably 
influenced by the coexistence of anti-idiotypic Ts2 in tyr(TMA)-immune  mice. 
Requirement  of a  CY-sensitive  Cell for Anti-Idiotypic  T~,-mediated  Suppression.  Because 
anti-idiotypic T~  function could only be demonstrated  by transfer into nai've recipi- 
ents,  we  reasoned  that  the  recipients  were  supplying  some  needed  cell  type  for 
suppressor function. Reports have recently emerged  (I 7,  18) describing a  CY-sensitive 
T  cell that is necessary in some systems for effector-phase Ts function and  is activated 
upon antigen priming. To test whether  this described cell was operating  in our system, 
we treated naive mice with high or low doses of CY either before or after immunization 
with  TMA-SC.  24  h  before  antigen  challenge,  spleen  cells  from  6-wk  tyr(TMA)- 
immune  mice were transferred into both the CY-treated  and control mice. As seen in 
TABLE  III 
Lack of Intrinsic Unresponsiveness  Is Not caused by Compensating CRI- Torn* 
CY  Anti-Id  Percent 
Immunization  treat-  inocula-  Response  suppres- 
ment  tion  sion 
rng  mrn ± l SEM 
Normal mice 
TMA-SC  --  -  1.23 +  0.05  (8)  -- 
TMA-SC  200  -  1.03 +  0.08 (4)  22 
TMA-SC  20  -  1.10 -I- 0.13 (4)  14 
TMA-SC  --  +  0.64 +  0.06 (9)  66 
TMA-SC  200  +  0.50 +  0.05 (5)  81 
TMA-SC  20  +  0.48 +  0.13 (4)  83 
tyr(TMA) immune mice 
TMA-SC  --  --  1.36 ±  0.07 (10)  -- 
TMA-SC  200  -  1.03 ±  0.03 (3)  32 
TMA-SC  20  -  1.42 -+ 0.12 (6)  -6 
TMA-SC  --  +  0.74 ±  0.12 (8)  60 
TMA-SC  200  +  0.52 zt: 0.06 (5)  82 
TMA-SC  20  +  0.72 -t- 0.06 (5)  62 
Negative Controls  --  -  0.33 ±  0.04 (11)  -- 
* Both normal A/J mice and mice inoculated intraperitoneally with tyr(TMA)  + 
FCA 6 wk before were immunized with 3 ×  107 TMA-SC and challenged in the 
footpad with the activated diazonium salt ofTMA 5 d later. Response was measured 
24 h after challenge, and the number of mice tested is given in parentheses. 200 mg 
CY was injected intraperitoneally 2 d before immunization with TMA-SC, and 20 
mg CY was injected 1 d  after immunization with TMA-SC.  Mice were  injected 
intravenously with 20 /zg IBC of anti-Id just before challenge.  Negative controls 
indicate naive mice challenged only. S. JAYARAMAN AND C. J.  BELLONE  1815 
Table IV, pretreatment of the recipients with either low or high doses of CY did not 
alter the  DTH  reaction induced by TMA-SC inoculation. However, these doses of 
CY markedly altered the ability of the transferred suppressor population to function 
when compared with the non-CY-treated control group  (Table IV). Thus, the data 
suggest that  the anti-idiotypic T~ require a  CY-sensitive cell, which is activated by 
antigen priming, to eventually suppress TMA-specific DTH. 
tyr(TMA )-immune Mice Lack a Critical Cell Type Involved in Ts~-mediated Suppression.  As 
previously pointed out, the CY-sensitive cell necessary for T~-mediated DTH  sup- 
pression can be activated by priming normal mice with TMA-SC. Based on this fact, 
we tested whether this procedure could activate the necessary cell type in tyr(TMA)- 
immune mice. To assay for this activity, both control and tyr(TMA)-immune mice 
were  primed  with  TMA-SC,  and  5  d  later  their  lymph  nodes  removed  and  the 
immune lymph  node  cells  (ILNC)  were  transferred  into  naive recipients with  or 
without splenic Ts from 6-wk tyr(TMA)-immune mice. As seen in Table V,  ILNC 
from normal mice (N-ILNC) transfer DTH but are suppressed by the addition of the 
splenic  T~  population.  No  such  suppression  of  DTH  was  observed  when  ILNC 
originated from the tyr(TMA)-immune  mice. To test whether ILNC from tyr(TMA)- 
immune mice can be suppressed, ILNC from both sources were mixed and transferred 
along with  the splenic suppressor cells into primed recipients. As seen in Table V, 
suppression of DTH was evident, indicating that the ILNC from the tyr(TMA) mice 
are indeed subject to suppression when mixed with N-ILNC. 
Phenotypic  Characteristics  of the ModulatoTy  T  Cell.  In this next series of experiments, 
we asked if the 6-wk tyr(TMA)-immune mice could be intrinsically suppressed if we 
TABLE IV 
Requirement of a CY-sensitive Cell Type Necessa(y  for Ts2-mediated 
Suppression * 
CY  Sup-  Percent 
Immunization  treat-  pressor  Response  suppres- 
ment  cells  sion 
mg  mm +  1 SEM 
Experiment A 
TMA-SC  --  -  1.13 ± 0.07 (3)  -- 
TMA-SC  200  -  1.03 + 0.08 (4)  14 
TMA-SC  --  +  0.73 ± 0.09 (4)  55:[: 
TMA-SC  200  +  1.08 ± 0.06 (5)  7 
Negative Controls  --  -  0.40 ± 0.12 (3)  -- 
Experiment B 
TMA-SC  --  -  0.80 ± 0.06 (3)  -- 
TMA-SC  20  -  0.75 ± 0.03 (4)  11 
TMA-SC  --  +  0.40 ± 0.04 (4)  85 
TMA-SC  20  +  0.78 ± 0.03 (6)  4 
Negative Controls  --  -  0.30 ± 0.03 (3)  -- 
* Normal A/J mice were immunized and challenged as described before. 200 
mg CY was injected 2 d before immunization, and 20 mg CY was injected 
1 d after immunization. 6 X  107 splenic suppressor cells were inoculated 
intravenously through a lateral tail vein 24 h before challenge. Suppressor 
cells were obtained from mice inoculated intraperitoneally with  100 #g of 
tyr(TMA) + FCA 6 wk before. Number of mice tested is given in parentheses. 
Negative controls indicate na'ive  mice  challenged only. 
~: Significantly different from positive controls; P < 0.02. 1816  IDIOTYPIC  T  CELLS THAT MODULATE  SUPPRESSION 
TABLE  V 
tyr(TMA)-immune Mice Lack a Critical Cell Type Needed  for Suppression * 
Percent 
Cells transferred  Suppres-  Response  suppres-  sor cells  sion 
mm± 1 SEM 
N-ILNC  -  0.76 ± 0.07 (5)  -- 
N-ILNC  +  0.40 ± 0.04 (4)  72 
tyr-ILNC  -  0.90 ± 0.09 (5)  -- 
tyr-ILNC  +  0.79 + 0.06 (7)  17 
N-ILNC + tyr-ILNC  -  0.88 :t: 0.04 (6)  -- 
N-ILNC + tyr-ILNC  +  0.46 + 0.07 (9)  68 
Negative controls  -  0.26 ± 0.02 (7) 
* Both normal (N)  and tyr(TMA) +  FCA-injected (6 wk before) A/J mice 
were immunized with 3 x  107 TMA-SC, and 5 d later their immune lymph 
nodes were removed. 3 X 10  7 viable lymph nodes were transferred intrave- 
nously into naive recipients with or without 6 X 10  7 splenic suppressor ceils 
derived from A/J mice injected with tyr(TMA) + FCA 6 wk before. In some 
experiments, 1 ×  10 7 N-ILNC and 2 X 10 7 tyr-ILNC were mixed immediately 
before transfer with or without additional splenic suppressor cells. All mice 
were challenged in the footpads within 1 h of cell transfer. Negative controls 
indicate the naive mice challenged only. Number of mice tested is given in 
parentheses. 
introduced ILNC  from  normal  mice  immunized with  TMA-SC  (N-ILNC)  before 
challenge. Normal A/J  mice were  immunized with  TMA-SC, and 5  d  later ILNC 
were harvested and transferred into tyr(TMA)-immune mice, which had been previ- 
ously primed with TMA-SC.  1 h  after cell transfer,  the  recipients were challenged 
with the diazonium salt of TMA, and the footpad swelling was recorded 24 h  later. 
As seen in Table VI, 6-wk tyr(TMA)-immune  mice, when immunized with TMA-SC, 
give a  normal DTH  response.  If N-ILNC are transferred just before challenge, the 
DTH  (group 2)  response is suppressed by 70%.  To characterize the cells that convert 
the tyr(TMA) mice to intrinsic suppressors, the N-ILNC were pretreated with various 
antibody reagents plus C  before transfer. These reagents were directed to the Thy-1, 
Lyt-2, and Lyt-1 antigens as well as the cross-reactive idiotypes associated with anti- 
TMA antibodies. As seen in Table VI, all of the antibody reagents, with the exception 
of the anti Lyt-1  (group 6), abolished the ability of the ceils to mediate suppression. 
Furthermore, we show that transfer of tyr(TMA) (group 7) ILNC into the tyr(TMA) 
mice  does  not  convert  these  mice,  confirming our  similar  previous  finding that 
tyr(TMA)-ILNC do  not  have  modulatory cell activity when transferred into na'ive 
animals (see Table V). To control for any specific or nonspecific suppressor element 
in the transfer system, either N-ILNC or ILNC from 6-wk tyr(TMA)-immune mice 
were transferred into normal mice immunized 5 d previously with TMA-SC. Transfer 
of these  populations into normal mice  (groups  17,  18)  had  no effect  on  the  DTH 
reaction.  Therefore,  it  would  appear  that  the  modulatory  cell  necessary  for  the 
function of Ts~ is itself a T  cell, bearing the Lyt-2 antigen as well as surface idiotypes. 
Because the ILNC transfer DTH as well as modulatory cell activity, we wanted to 
determine if the cells mediating DTH could be phenotypically distinguished from the S. JAYARAMAN AND C. J.  BELLONE 
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Phenotype of the Modulatory Cells and TDTn* 
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Percent 









8  Naive mice 
9  Naive mice 
10  Naive mice 
11  Naive mice 
12  Naive mice 
13  Naive mice 
14  Naive mice 
15  Naive mice 
16  Normal mice 
17  Normal mice 
18  Normal mice 
mm+ l SEM 
None  1.02 ±  0.03 (37)  -- 
N-ILNC + 12  0.55 ± 0.03 (18)  70 
N-ILNC +  anti-'lShy-1 + C  0.88 ± 0.09 (6)  21 
N-ILNC +  anti-Id + C  0.85 ± 0.03 (!0)  25 
N-ILNC +  anti-Lyt-2 + C  0.82 ± 0.05 (6)  30 
N-ILNC +  anti-Lyt-1  + C  0.64 ±  0.02 (5)  57 
tyr-ILNC+ C  0.96 ± 0.09 (5)  9 
None  0.35 ±  0.01 (30)  -- 
N-ILNC 4- C  0.72 :!: 0.04 (20)  --- 
N-ILNC +  anti-Thy-1 +  C  0.26 ±  0.03 (7)  124 
N-ILNC + anti-Id +  C  0.43 ±  0.07 (8)  78 
N-ILNC + anti-Lyt-2 +  C  0.62 ± 0.03 (6)  27 
N-ILNC 4- anti-Lyt-1  +  C  0.28 ± 0.03 (6)  119 
tyr-ILNC + 12  0.91 ± 0.06 (9)  -- 
tyr-ILNC + anti-Id +  C  0.54 ± 0.05 (8)  66 
None  0.87 ± 0.07 (6)  -- 
N-ILNC + C  0.95 ± 0.03 (4)  -15 
tyr-ILNC +  12  0.78 ± 0.03 (4)  17 
* tyr(TMA) +  FCA injected (6 wk before) and untreated normal A/J mice were immunized with 3 ×  l07 
TMA-SC, and 5 d later lymph nodes were removed from some of them. The remaining mice served as 
the recipients  of lymph node cells. In addition, nonimmune, nai've A/J mice were used as recipients to 
monitor for the ability of treated lymph node cells to transfer DTH (line 9-15). The lymph node cells 
were treated with several  reagents as indicated, washed extensively,  and transferred intravenously into 
appropriate recipients.  Nonimmune, naive mice received no cells served as negative controls (line 8)~ All 
mice were challenged in the footpad within 1 h of cell transfer,  and the footpad swelling was recorded 24 
h later.  Data from eight experiments were pooled.  Number of animals tested  is given in parentheses. 
modulatory cell population. Accordingly, we treated the ILNC with the same reagents 
used  in  the previous experiments  and  then  tested  the ability of these  treated  cells to 
transfer TMA  specific DTH.  The transfer of DTH  is abolished by (group  10,  11) anti- 
Thy-1  and  the  anti-Id  reagent,  the  latter  confirming  our  previous  contention  that 
TDTH bear  idiotypic  determinants.  However,  the  anti-Lyt-2  +  C  treatment  did  not 
affect  the ability of ILNC  to  transfer  DTH,  whereas  the anti-Lyt-1  +  C  completely 
abolished  the  transfer  of DTH.  In  addition,  the  ability  of  ILNC  from  tyr(TMA) 
(group  15)  mice  to  transfer  DTH  was  greatly  affected  by  treatment  with  anti-Id 
antibodies,  confirming  that  the  TDTH  present  in  tyr(TMA)  mice  are  similar  to  the 
TDTH in  normal  mice.  However,  the  ability of ILNC  from  2,4-dinitrofluorobenzene 
(DNFB)-painted  A/J  mice  to  transfer  contact  sensitivity  was  not  abolished  after 
treatment  with  anti-Id  and  C,  confirming  the  specificity  of the  reagent  (data  not 
shown).  Thus,  the TDTn are Id  +, Lyt- 1+,2-;  the modulatory T  cells are Id  +, Lyt- 1-,2 +. 
In summary,  it would appear  that  the inability of anti-idiotypic Ts2-bearing  mice to 
exhibit  intrinsic  unresponsiveness  is  caused  by  the  lack  of function  in  an  antigen- 
primed,  Thy-1 +, Id  +, Lyt-1-,2 + modulatory  cell population. 1818  IDIOTYPIC T  CELLS THAT MODULATE SUPPRESSION 
Discussion 
We have reported earlier that  a  single intraperitoneal  injection of tyr(TMA)  in 
FCA in A/J mice induced a suppressor cell population that was able to suppress the 
TMA-specific DTH responses when adoptively transferred into na'ive mice  (12).  In 
addition, it was observed that these Ts (termed Ts2 [8]) bear anti-idiotypic receptors, 
Lyt-2 alloantigen, and I-J subregion-encoded products and were both H-2- and Igh- 
V-restricted for their action (12). The data presented in this report demonstrate that 
Ts2 can suppress not only the TMA-SC-induced DTH but also the anti-Id-induced 
DTH when adoptively transferred into normal recipients at the effector phase (Table 
I).  However,  when  these  T~-bearing  tyr(TMA)-immune  mice  were  intentionally 
immunized with either TMA-SC or anti-Id, they failed to exhibit intrinsic unrespon- 
siveness.  This  paradoxical  observation,  wherein  the  presence  of Ts2  can  only  be 
demonstrated  by  adoptive  transfer  into  normal  recipients  but  failed  to  function 
intrinsically, is not caused by the inability of A/J mice in general to exhibit intrinsic 
unresponsiveness. This conclusion is based on the finding that  2 wk after tyr(TMA) 
+  FCA injection, A/J mice exhibited intrinsic unresponsiveness (Table II). However, 
the T~ induced at this time were found to bear idiotype, act only at the induction 
phase  of DTH when  adoptively transferred into normal  recipients, and  the  factor 
extracted from these "Is found to act across MHC barriers (manuscript in preparation). 
Thus,  it  is  clear  that  the  reason  for  the  failure  to  observe  suppressor  activity 
intrinsically in mice bearing anti-idiotypic T~2 is not caused by the general inability 
of A/J  mice  to  exhibit  intrinsic  unresponsiveness.  The  fact  that  a  normal  DTH 
response can be evoked in T~2-bearing mice with anti-Id (Table I) suggests that the 
DTH response in  these  mice is  not  qualitatively different from normal  mice. This 
contention is  further supported by two  lines of evidence.  Previously  (14)  we  have 
shown  that  the  intravenous  administration  of a  large  dose  of anti-Id just  before 
challenge blocked the DTH responses specific to TMA. In addition, it was observed 
that  this mode of blocking of DTH occurred only in strains of mice possessing the 
same allotype as that of A/J strain, suggesting the presence of Id on the surface of 
TDTn. To rule out the possibility that the anti-Id-induced blocking of DTH was not 
caused by the activation of suppressor cells, the mice were treated with doses of CY 
known to deplete suppressor T  cell precursors (19-24). Irrespective of the treatment 
to mice with CY, DTH induced in normal as well as in tyr(TMA)-immune mice was 
effectively blocked with anti-Id (Table III), suggesting the presence of Id on TDTH as 
observed in other systems (25,  26). Direct evidence for the function of the idiotypic 
component of TDTH in tyr(TMA)-immune mice comes from experiments involving 
treatment  of TDTH with anti-Id +  C  before adopti.ve transfer into naive recipients. 
Such  a  treatment  abolished  the  ability  of TD'rH  derived  from  normal  as  well  as 
tyr(TMA)-immune ice to transfer immunity into naive recipients (Table VI, groups 
9, 11, 14, and  15) equally well. Taken together, these results strongly indicate that the 
idiotypic component of  TDTH was not functionally deleted as a result of the coexistence 
of anti-idiotypic Ts2 in tyr(TMA)-immune mice. 
The  notion  that  the  auxiliary  cells  may  help  the  manifestation  of suppressor 
function has been previously suggested (8,  17,  18, 27-31). Such auxiliary (17) or T~a 
(18, 30, 31) cells have been shown to be essential for the function of anti-idiotypic T~2 
in nitrophenylacetyl-specific cutaneous hypersensitivity (18) and azobenzenearsonate- 
specific DTH  (30)  systems. Based on the fact that anti-idiotypic T~ cannot intrinsi- S. JAYARAMAN AND C. J.  BELLONE  1819 
cally suppress the DTH, it was reasoned that this apparent inability of T~2 to function 
could be caused by the loss of the function of a cell type similar to an auxiliary or T~ 
cell. Data in Table IV suggest that the ability of T~2 to suppress the DTH response 
when adoptively transferred into normal mice at  the effector phase depends on an 
antigen-activated, CY-sensitive suppressor cell type in the recipients. This is in line 
with the findings that the CY-sensitive auxiliary (17) or T~ cells (18)  are needed for 
the manifestation of effector-phase suppressors. It is likely that an absence of this CY- 
sensitive suppressor cell activity, induced after TMA-SC  immunization,  is a  major 
factor in the lack of expression of suppressor activity intrinsically in T~-bearing mice. 
Further experiments in fact indicated that the ILNC from tyr(TMA)-immune mice 
were not suppressed when adoptively transferred together with T~ into naive recipi- 
ents (Table V). However, the addition of ILNC from normal mice to ILNC derived 
from tyr(TMA)-immune mice conferred the ability to be suppressed by T~. It is thus 
evident that the anti-idiotyic, Lyt-2  +, I-J  + T,2 is not the effector suppressor, but the 
CY-sensitive cell type present in the antigen-activated immune lymphoid population 
could bring about suppression of TMA-specific DTH. Because the presence or absence 
of the function of the latter cell type determines whether suppression should occur, 
this cell type will be referred to as "modulatory" as suggested (32). 
Because the transfer protocols do not really mimic the physiological situation,  it 
was  decided  to  see  if  we  could  convert  the  T~-bearing  mice  into  intrinsically 
suppressed  mice  by providing activated  modulatory cell populations  from normal 
mice. The data show that it is possible to make the T~2 functional in situ by providing 
extraneous  modulatory cells  (Table VI).  In  addition,  it  was  shown  that  the  cells 
responsible for the function of T~ are T  cells that bear Lyt-2 alloantigen as previously 
shown for the T~ (18) and amplifier of suppressor cells (28). Like the target cell of T~2 
in another system (30), the modulatory cells involved in TMA-specific T~-mediated 
DTH suppression also bear the Id on their surface. It should be noted that  the T~ 
cells have been shown to bear the I-J subregion-encoded products and are restricted 
by H-2 and Igh-complex products (18).  Thus, it appears that  the modulatory cells, 
which  are  nonfunctional  in  anti-idiotypic  T~2-bearing  mice,  share  many  of the 
properties attributed to auxiliary (17), Ts3 (18, 30), and amplifier of suppressor cells 
(28). The consensus from all these studies is that the modulatory cells are very critical 
for the expression of  suppressor activity and may be the final cell type in the suppressor 
pathway (8, 30, 31). Because both TDTH and modulatory cells appear to bear Id on 
their surface (Table VI), and the stimulation of Ts2 or modulatory cell alone do not 
bring  about  any  suppression,  these  data  support  the  hypothesis  that  the  Tee and 
modulatory cells interact with each other by Id-anti-Id recognition, which releases a 
factor that directly or indirectly suppress the function of TDTH (8, 30, 31). 
We have previously shown  (11)  that if 6-wk tyr(TMA)-immune mice were inocu- 
lated with TMA coupled to a  protein, the resulting anti-TMA antibody lacked the 
Id  + component of the response, which normally constitutes on an average 50% of the 
response. Because this suppressor activity is T~2 mediated, an apparent difference in 
the ability of these mice to intrinsically modulate antibody vs. DTH responses exists. 
The discrepancy between the results would indicate that T~ may act directly on Id  ÷ 
B  cells  through  direct  receptor interaction  (33,  34)  or through  an  antigen  bridge. 
Alternatively, the immunization protocol used to generate antibody production could 
have activated the modulatory population. At present we cannot rule out any one of 1820  IDIOTYPIC T  CELLS THAT MODULATE SUPPRESSION 
these possibilities. Nevertheless, under a  certain set of conditions the T~2 population 
is unable to shut down DTH but can mediate suppression at the humoral level. Taken 
together, the results indicate that the modulatory population can potentially play a 
strategic  role  in  immune  regulation.  In  this  particular  situation  the  modulatory 
population  can  split  control-mediated  by  Ts2  cells,  allowing  the  suppression  of 
antibody  on  one  hand  and  intact  DTH  responses  on  the  other.  Rather  than  the 
necessity  to  regulate  a  variety of responses  at  the  Ts2  level,  which  would  remove 
suppressor  potential  at  both  the  antibody  and  DTH  levels,  the  system  via  the 
modulatory  cell  is  now  capable  of a  more  sophisticated  form  of control  or  "fine 
tuning."  Thus,  the  induction  of T~  using  tyr(TMA)  in  FCA  appears  to  offer the 
potential to study the fine regulation of antibody and DTH responses in a  naturally 
controlled fashion. 
Summary 
A single intraperitoneal injection of the monovalent synthetic antigen, tyrosinated 
trimethylaminoaniline  [tyr(TMA)]  in  Freund's complete adjuvant  induces  an anti- 
idiotypic second-order T  suppressor (Ts2) cell population 6 wk later. This population 
was  able  to  suppress  TMA-specific delayed-type hypersensitivity  (DTH)  responses 
when adoptively transferred into normal syngeneic recipients. However, they failed to 
function intrinsically. The inability of the Ts2 to function intrinsically was not caused 
by compensating idiotype-negative T  cells that mediate DTH. Rather, this paradox- 
ical observation was found to be caused by the absence or loss of function of a critical 
modulatory  T  cell  population  in  the  suppressor  cell-bearing  mice.  This  cell  is 
functionally active in normal mice immunized for DTH responses and is sensitive to 
cyclophosphamide treatment. In addition, this cell type bears idiotype on its surface 
and is Thy-1 + and Lyt-1-,2  +. It was demonstrated that by adoptively transferring the 
activated modulatory T  cells from normal mice into tyr(TMA)-immune recipients, it 
was possible to observe suppressor cell function intrinsically. The potential importance 
of modulatory T  cell function  in  the regulation  of antibody and  DTH responses is 
discussed. 
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